Reducing Chronic Kidney Disease Burden in an Underserved Population

Completed · Not applicable

Conditions studied: CKD, ESRD

In brief

To evaluate a scalable population health strategy to 1) screen, 2) identify, and 3) intervene with individuals at high risk of CKD progression to ESRD that could be implemented in other high risk communities and health care systems. This novel study will evaluate the feasibility and preliminary efficacy of providing F\&V to individuals identified at high risk study for CKD and ESRD through community health screenings. Further, it will evaluate whether providing education as to how to prepare F\&V for consumption, the latter being done for all F\&V recipients in PI's preliminary published studies but its efficacy was not specifically tested, increases F\&V intake and thereby reduces CKD progression risk as well as related clinical outcomes.

Key facts

Study ID

NCT03832166

Run by

Baylor Research Institute

People needed

142

Starts

2019-01-24

Expected to finish

2020-07-14

Last updated by the study team

2020-11-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Willingness to participate in 6 month F\&V study
• Positive urine dipstick.
• African American (self declared) race
• Access to internet via personal computer or mobile device
• Ability to read and write in English

You may not qualify if…

• Negative urine dipstick
• Currently receiving dialysis or needing dialysis (stage 5 Kidney disease)
• Have received or need kidney transplant
• Pregnant or plan to become pregnant in the next 6 months
• Baseline urine potassium > 60 mEq/g creatinine
• Nephrotic proteinuria demonstrated on urine ACR measurement
• Lacking access to the internet via personal computer or mobile device
• Unable to read or write in English

Where it is running

• Baylor Research Institute — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.